ARCHIVES

Georgetown Sponsors Oncology Agent Development Meeting

This article is from The Cancer Letter archive.

Vol. 29 No. 08 | February 21, 2003

Download PDF Visit The Full Archive

Related Articles

Cediranib/Olaparib Combination Nearly Doubles PFS in Phase II

September 26, 2014

Genentech Move Nixes Hospital Discounts: Avastin, Herceptin, Rituxan Now Sold Under Tighter Control by Drug Maker

October 3, 2014

FDA To Once Again Review ESA Label To Reflect Results Of Negative Studies.

December 7, 2007

DCT Board Approves Concepts For Acoustic Microscopy, Taxol Development, AIDS R&D

June 15, 1990

Tobacco Control Bill Requires Stronger Warnings

August 10, 1990

Funding Opportunities

November 15, 2002